Cytrx Corp (NASDAQ:CYTR)

CAPS Rating: 2 out of 5

A biopharmaceutical research and development company engaged in developing human therapeutic products based primarily upon its small molecule molecular chaperone co-induction technology.

Recs

1
Player Avatar DarkKnightWins (< 20) Submitted: 11/6/2006 10:13:58 AM : Outperform Start Price: $5.80 CYTR Score: -60.07

Awesome company. One of the few with very good trials out there for ALS... My top pick in my portfolio

Featured Broker Partners


Advertisement